W Liu1, J Zhu, L Cao, G P Rodgers. 1. Molecular and Clinical Hematology Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract
AIMS: The human G-CSF-stimulated clone-1 (hGC-1) gene encodes a 510-amino acid olfactomedin-related glycoprotein whose exact in vivo localization and function still remain elusive. The aim of this study was to demonstrate hGC-1 protein localization in the normal human gastrointestinal tract and to explore further a potential relationship between hGC-1 expression and gastric carcinoma. METHODS AND RESULTS: A specific hGC-1 polyclonal antibody raised against purified hGC-1 protein was developed and characterized. Using immunohistochemistry, it was demonstrated that hGC-1 is expressed in the oesophagus, stomach, small intestine and colon. The expression pattern of hGC-1 protein in 173 cases of gastric carcinoma was investigated and a striking correlation was demonstrated between hGC-1 expression and histological type and differentiation of gastric carcinoma. Enhanced hGC-1 expression was more frequently seen in intestinal-type adenocarcinoma, whereas loss of expression tended to occur in the diffuse type. hGC-1 was highly expressed in well or moderately differentiated cancers and was remarkably reduced or lost in poorly differentiated or undifferentiated tumours. CONCLUSIONS: These investigations have defined for the first time the expression pattern of hGC-1 in the normal human gastrointestinal tract and provide a novel and sensitive marker for the differentiation of gastric carcinoma.
AIMS: The human G-CSF-stimulated clone-1 (hGC-1) gene encodes a 510-amino acid olfactomedin-related glycoprotein whose exact in vivo localization and function still remain elusive. The aim of this study was to demonstrate hGC-1 protein localization in the normal humangastrointestinal tract and to explore further a potential relationship between hGC-1 expression and gastric carcinoma. METHODS AND RESULTS: A specific hGC-1 polyclonal antibody raised against purified hGC-1 protein was developed and characterized. Using immunohistochemistry, it was demonstrated that hGC-1 is expressed in the oesophagus, stomach, small intestine and colon. The expression pattern of hGC-1 protein in 173 cases of gastric carcinoma was investigated and a striking correlation was demonstrated between hGC-1 expression and histological type and differentiation of gastric carcinoma. Enhanced hGC-1 expression was more frequently seen in intestinal-type adenocarcinoma, whereas loss of expression tended to occur in the diffuse type. hGC-1 was highly expressed in well or moderately differentiated cancers and was remarkably reduced or lost in poorly differentiated or undifferentiated tumours. CONCLUSIONS: These investigations have defined for the first time the expression pattern of hGC-1 in the normal humangastrointestinal tract and provide a novel and sensitive marker for the differentiation of gastric carcinoma.
Authors: Wenli Liu; Ming Yan; Yueqin Liu; Ruihong Wang; Cuiling Li; Chuxia Deng; Aparna Singh; William G Coleman; Griffin P Rodgers Journal: Proc Natl Acad Sci U S A Date: 2010-06-01 Impact factor: 11.205
Authors: Hellen Dassen; Chamindie Punyadeera; Bert Delvoux; Iris Schulkens; Claudia Marchetti; Rick Kamps; Jan Klomp; Fred Dijcks; Anton de Goeij; Thomas D'Hooghe; Cleophas Kyama; Antwan Ederveen; Gerard Dunselman; Patrick Groothuis; Andrea Romano Journal: Am J Pathol Date: 2010-11 Impact factor: 4.307
Authors: Wenli Liu; Ming Yan; Yueqin Liu; Kenneth R McLeish; William G Coleman; Griffin P Rodgers Journal: J Immunol Date: 2012-07-27 Impact factor: 5.422
Authors: Josane F Sousa; Amy-Joan L Ham; Corbin Whitwell; Ki Taek Nam; Hyuk-Joon Lee; Han-Kwang Yang; Woo Ho Kim; Bing Zhang; Ming Li; Bonnie LaFleur; Daniel C Liebler; James R Goldenring Journal: Am J Pathol Date: 2012-09-01 Impact factor: 4.307